top
Search terms
Results 1 - 10 of 106 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 11
Ejhf

[1, 2] Although the majority of patients with PH are classified into group 2 (PH due to left heart disease) or 3 (PH due to lung diseases and/or hypoxia), the PH group that has received most ...

European Journal of Heart Failure, Konstantinides, Stavros V.

Date : 01/09/2016 Item size : 78800 bytes
Ehjournal

Mattle and co-workers present PRIMA, a randomized clinical trial comparing patent foramen ovale (PFO) closure using the Amplatzer occluder with medical management in patients suffering from migraine ...

European Heart Journal, Luft, Andreas R.

Date : 07/07/2016 Item size : 170544 bytes
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016
Ehjacc

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, Héctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016